𝗙𝗿𝗼𝗺 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗶𝗻𝘁𝗼 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 - 𝗔 𝗚𝗢-𝗕𝗶𝗼 𝗶𝗻𝗶𝘁𝗶𝗮𝗹 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗯𝘆 𝗔𝘀𝗰𝗲𝗻𝗶𝗼𝗻
Join us on 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟲 to gain valuable insights on the GO-Bio initial funding programme for innovative ideas in early stages of development!
👉 Register now: www.ascenion.de/service/go-b...
𝗙𝗿𝗼𝗺 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝗶𝗻𝘁𝗼 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 - 𝗔 𝗚𝗢-𝗕𝗶𝗼 𝗶𝗻𝗶𝘁𝗶𝗮𝗹 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗪𝗲𝗯𝗶𝗻𝗮𝗿 𝗯𝘆 𝗔𝘀𝗰𝗲𝗻𝗶𝗼𝗻
Join us on 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟭𝟲 to gain valuable insights on the GO-Bio initial funding programme for innovative ideas in early stages of development!
👉 Register now: www.ascenion.de/service/go-b...
𝐎𝐫𝐚𝐥 𝐀𝐧𝐭𝐢𝐦𝐨𝐭𝐢𝐥𝐢𝐧-𝐁𝐚𝐬𝐞𝐝 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐟𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐇𝐞𝐥𝐢𝐜𝐨𝐛𝐚𝐜𝐭𝐞𝐫 𝐩𝐲𝐥𝐨𝐫𝐢 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬
🔬 Ludwig-Maximilians-Universität München #LMU
🔬 Hannover Medical School #MHH
🔬 Helmholtz-Zentrum für Infektionsforschung #HZI
@helmholtzhzi.bsky.social
#HelicobacterPylori #GastricCancer #Antimotilin
𝐎𝐫𝐚𝐥 𝐀𝐧𝐭𝐢𝐦𝐨𝐭𝐢𝐥𝐢𝐧-𝐁𝐚𝐬𝐞𝐝 𝐈𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫𝐬 𝐟𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐇𝐞𝐥𝐢𝐜𝐨𝐛𝐚𝐜𝐭𝐞𝐫 𝐩𝐲𝐥𝐨𝐫𝐢 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧𝐬
🔬 Ludwig-Maximilians-Universität München #LMU
🔬 Hannover Medical School #MHH
🔬 Helmholtz-Zentrum für Infektionsforschung #HZI
@helmholtzhzi.bsky.social
#HelicobacterPylori #GastricCancer #Antimotilin
𝗡𝗼𝘃𝗲𝗹 𝗖𝗔𝗥𝘀 𝗳𝗼𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 𝗮𝗻𝗱
𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿´𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲
🔬 Medizinische Hochschule Hannover
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
#ChimericAntigenReceptor #Treg #Immunotherapy #CellTherapy
𝗡𝗼𝘃𝗲𝗹 𝗖𝗔𝗥𝘀 𝗳𝗼𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗦𝗰𝗹𝗲𝗿𝗼𝘀𝗶𝘀 𝗮𝗻𝗱
𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿´𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲
🔬 Medizinische Hochschule Hannover
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
#ChimericAntigenReceptor #Treg #Immunotherapy #CellTherapy
𝗠𝗮𝗶𝗻𝘁𝗲𝗻𝗮𝗻𝗰𝗲 𝗼𝗳 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗧 𝗰𝗲𝗹𝗹 𝗽𝗵𝗲𝗻𝗼𝘁𝘆𝗽𝗲 𝗯𝘆 𝗲𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗼𝗳 𝗜𝗟-𝟮 𝗳𝘂𝘀𝗶𝗼𝗻 𝗽𝗿𝗼𝘁𝗲𝗶𝗻
🔬 Medizinische Universität Innsbruck - @i-med.ac.at
👉 Learn more about this #technology on our website:
www.ascenion.de/en/technolog...
𝗠𝗮𝗶𝗻𝘁𝗲𝗻𝗮𝗻𝗰𝗲 𝗼𝗳 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗧 𝗰𝗲𝗹𝗹 𝗽𝗵𝗲𝗻𝗼𝘁𝘆𝗽𝗲 𝗯𝘆 𝗲𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗼𝗳 𝗜𝗟-𝟮 𝗳𝘂𝘀𝗶𝗼𝗻 𝗽𝗿𝗼𝘁𝗲𝗶𝗻
🔬 Medizinische Universität Innsbruck - @i-med.ac.at
👉 Learn more about this #technology on our website:
www.ascenion.de/en/technolog...
𝗜𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗼𝗳 𝗣𝗿𝗼𝗸𝗮𝗿𝘆𝗼𝘁𝗶𝗰 𝗧𝗼𝗽𝗼𝗶𝘀𝗼𝗺𝗲𝗿𝗮𝘀𝗲 𝗜
🔬 @helmholtzhzi.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗜𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗼𝗳 𝗣𝗿𝗼𝗸𝗮𝗿𝘆𝗼𝘁𝗶𝗰 𝗧𝗼𝗽𝗼𝗶𝘀𝗼𝗺𝗲𝗿𝗮𝘀𝗲 𝗜
🔬 @helmholtzhzi.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗡𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲𝘀 𝗳𝗼𝗿 𝗩𝗶𝗿𝗮𝗹 𝗖𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲
🔬 @leibniz-hki.de I www.leibniz-hki.de/de/molekular...
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗡𝗮𝗻𝗼𝗽𝗮𝗿𝘁𝗶𝗰𝗹𝗲𝘀 𝗳𝗼𝗿 𝗩𝗶𝗿𝗮𝗹 𝗖𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲
🔬 @leibniz-hki.de I www.leibniz-hki.de/de/molekular...
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗡𝗹𝘂𝗰-𝗕𝗮𝘀𝗲𝗱 𝗖𝘆𝘁𝗼𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝘆 𝗔𝘀𝘀𝗮𝘆
🔬 @leibniz-hki.de
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗡𝗹𝘂𝗰-𝗕𝗮𝘀𝗲𝗱 𝗖𝘆𝘁𝗼𝘁𝗼𝘅𝗶𝗰𝗶𝘁𝘆 𝗔𝘀𝘀𝗮𝘆
🔬 @leibniz-hki.de
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗧𝗵𝗶𝗼𝘂𝗿𝗲𝗮 𝗔𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰𝘀 𝗳𝗼𝗿 𝗔𝗰𝗶𝗻𝗲𝘁𝗼𝗯𝗮𝗰𝘁𝗲𝗿 𝗯𝗮𝘂𝗺𝗮𝗻𝗻𝗶𝗶
🔬 @helmholtzhzi.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
#Antibiotics #AMR #Acinetobacter #GramNegative #InfectiousDiseases #SmallMolecule #ESKAPE
𝗧𝗵𝗶𝗼𝘂𝗿𝗲𝗮 𝗔𝗻𝘁𝗶𝗯𝗶𝗼𝘁𝗶𝗰𝘀 𝗳𝗼𝗿 𝗔𝗰𝗶𝗻𝗲𝘁𝗼𝗯𝗮𝗰𝘁𝗲𝗿 𝗯𝗮𝘂𝗺𝗮𝗻𝗻𝗶𝗶
🔬 @helmholtzhzi.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
#Antibiotics #AMR #Acinetobacter #GramNegative #InfectiousDiseases #SmallMolecule #ESKAPE
𝗠𝗲𝘁𝗵𝗼𝗱 𝗳𝗼𝗿 𝗔𝘀𝘀𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘂𝘁-𝗼𝗳-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 (𝗢𝗢𝗦) 𝗖𝗔𝗥 𝗧-𝗖𝗲𝗹𝗹 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝗮𝗻𝗱 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲
🔬 Charité - Universitätsmedizin Berlin
🔬 @bihatcharite.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗠𝗲𝘁𝗵𝗼𝗱 𝗳𝗼𝗿 𝗔𝘀𝘀𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘂𝘁-𝗼𝗳-𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 (𝗢𝗢𝗦) 𝗖𝗔𝗥 𝗧-𝗖𝗲𝗹𝗹 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝗮𝗻𝗱 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗲
🔬 Charité - Universitätsmedizin Berlin
🔬 @bihatcharite.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
Join us on July 9 for our second market analysis workshop:
"Keep Your Friends Close, but Enemies Closer: Understanding Your Competitive Landscape" with our expert Dr. Rebekka Müller!
📅 Date: July 9, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
Join us on July 9 for our second market analysis workshop:
"Keep Your Friends Close, but Enemies Closer: Understanding Your Competitive Landscape" with our expert Dr. Rebekka Müller!
📅 Date: July 9, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
𝗜𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗼𝗳 𝗘𝗻𝗲𝗿𝗴𝘆 𝗖𝗼𝘂𝗽𝗹𝗶𝗻𝗴 𝗙𝗮𝗰𝘁𝗼𝗿 (𝗘𝗖𝗙) 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁𝗲𝗿𝘀 𝗔𝗴𝗮𝗶𝗻𝘀𝘁 𝗚𝗿𝗮𝗺-𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗣𝗮𝘁𝗵𝗼𝗴𝗲𝗻𝘀
🔬 @helmholtzhzi.bsky.social (#HZI)
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗜𝗻𝗵𝗶𝗯𝗶𝘁𝗼𝗿𝘀 𝗼𝗳 𝗘𝗻𝗲𝗿𝗴𝘆 𝗖𝗼𝘂𝗽𝗹𝗶𝗻𝗴 𝗙𝗮𝗰𝘁𝗼𝗿 (𝗘𝗖𝗙) 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁𝗲𝗿𝘀 𝗔𝗴𝗮𝗶𝗻𝘀𝘁 𝗚𝗿𝗮𝗺-𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗣𝗮𝘁𝗵𝗼𝗴𝗲𝗻𝘀
🔬 @helmholtzhzi.bsky.social (#HZI)
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝗠𝗲𝘁𝗵𝗼𝗱 𝗳𝗼𝗿 𝗱𝗶𝗿𝗲𝗰𝘁 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗮𝘃𝗶𝗱𝗶𝘁𝘆 𝗼𝗳 𝗧 𝗰𝗲𝗹𝗹𝘀
🔬 @Charité - Universitätsmedizin Berlin
🔬 @bihatcharite.bsky.social
🔎 Learn more about this #technology on our website:
www.ascenion.de/technologiea...
𝗠𝗲𝘁𝗵𝗼𝗱 𝗳𝗼𝗿 𝗱𝗶𝗿𝗲𝗰𝘁 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗳𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹 𝗮𝘃𝗶𝗱𝗶𝘁𝘆 𝗼𝗳 𝗧 𝗰𝗲𝗹𝗹𝘀
🔬 @Charité - Universitätsmedizin Berlin
🔬 @bihatcharite.bsky.social
🔎 Learn more about this #technology on our website:
www.ascenion.de/technologiea...
Join us on June 25 for our workshop "Know Your Playground: Understanding Your Market" with our expert Dr. Rebekka Müller.
📅 Date: June 25, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
Join us on June 25 for our workshop "Know Your Playground: Understanding Your Market" with our expert Dr. Rebekka Müller.
📅 Date: June 25, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
Thx to @asceniongmbh.bsky.social & all involved!
#Workshop #TechTransfer #BMFTR #LeibnizHKI
🌐 More on ATHANA: lmy.de/tAmvm
Thx to @asceniongmbh.bsky.social & all involved!
#Workshop #TechTransfer #BMFTR #LeibnizHKI
🌐 More on ATHANA: lmy.de/tAmvm
Join us on June 25 for our workshop "Know Your Playground: Understanding Your Market" with our expert Dr. Rebekka Müller.
📅 Date: June 25, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
Join us on June 25 for our workshop "Know Your Playground: Understanding Your Market" with our expert Dr. Rebekka Müller.
📅 Date: June 25, 2025
🕒 Time: 4.00 - 5.30 pm CET
👉 Register now: www.ascenion.de/service/go-b...
𝐆𝐞𝐧𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐚𝐬𝐞 𝟑 𝐚𝐮𝐭𝐨𝐚𝐧𝐭𝐢𝐠𝐞𝐧 𝐚𝐬 𝐚 𝐧𝐨𝐯𝐞𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐀𝐍𝐂𝐀-𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐯𝐚𝐬𝐜𝐮𝐥𝐢𝐭𝐢𝐬
🔬 Charité - Universitätsmedizin Berlin
🔬 @mdc-berlin.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝐆𝐞𝐧𝐞 𝐞𝐝𝐢𝐭𝐢𝐧𝐠 𝐨𝐟 𝐭𝐡𝐞 𝐩𝐫𝐨𝐭𝐞𝐢𝐧𝐚𝐬𝐞 𝟑 𝐚𝐮𝐭𝐨𝐚𝐧𝐭𝐢𝐠𝐞𝐧 𝐚𝐬 𝐚 𝐧𝐨𝐯𝐞𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐀𝐍𝐂𝐀-𝐚𝐬𝐬𝐨𝐜𝐢𝐚𝐭𝐞𝐝 𝐯𝐚𝐬𝐜𝐮𝐥𝐢𝐭𝐢𝐬
🔬 Charité - Universitätsmedizin Berlin
🔬 @mdc-berlin.bsky.social
🔎 Learn more about this #technology on our website: www.ascenion.de/technologiea...
𝐁𝐫𝐨𝐚𝐝-𝐬𝐩𝐞𝐜𝐭𝐫𝐮𝐦 𝐚𝐧𝐭𝐢𝐯𝐢𝐫𝐚𝐥 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝𝐬 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐤𝐧𝐨𝐰𝐧 𝐚𝐧𝐝 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐯𝐢𝐫𝐮𝐬𝐞𝐬
👩🔬 Elke Bogner
👨🔬 Vadim Makarov
🔬 @Charité - Universitätsmedizin Berlin
🔎 Learn more about this #technology on our website: lnkd.in/dYjbvWxN
𝐁𝐫𝐨𝐚𝐝-𝐬𝐩𝐞𝐜𝐭𝐫𝐮𝐦 𝐚𝐧𝐭𝐢𝐯𝐢𝐫𝐚𝐥 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝𝐬 𝐚𝐠𝐚𝐢𝐧𝐬𝐭 𝐤𝐧𝐨𝐰𝐧 𝐚𝐧𝐝 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐯𝐢𝐫𝐮𝐬𝐞𝐬
👩🔬 Elke Bogner
👨🔬 Vadim Makarov
🔬 @Charité - Universitätsmedizin Berlin
🔎 Learn more about this #technology on our website: lnkd.in/dYjbvWxN
𝐀𝐈-𝐛𝐚𝐬𝐞𝐝 𝐌𝐞𝐭𝐡𝐨𝐝 𝐚𝐧𝐝 𝐓𝐨𝐨𝐥 (#𝐃𝐞𝐞𝐩𝐍𝐞𝐨) 𝐟𝐨𝐫 𝐈𝐧𝐭𝐫𝐚𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐎𝐩𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐜𝐞 𝐓𝐨𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐈𝐦𝐚𝐠𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐂𝐨𝐫𝐨𝐧𝐚𝐫𝐲 𝐀𝐫𝐭𝐞𝐫𝐲 𝐍𝐞𝐨𝐢𝐧𝐭𝐢𝐦𝐚𝐥 𝐓𝐢𝐬𝐬𝐮𝐞
🔬 @www.helmholtz-munich.de I TUM Klinikum Deutsches Herzzentrum
🔎 Learn more:
www.ascenion.de/technologiea...
𝐀𝐈-𝐛𝐚𝐬𝐞𝐝 𝐌𝐞𝐭𝐡𝐨𝐝 𝐚𝐧𝐝 𝐓𝐨𝐨𝐥 (#𝐃𝐞𝐞𝐩𝐍𝐞𝐨) 𝐟𝐨𝐫 𝐈𝐧𝐭𝐫𝐚𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐎𝐩𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐜𝐞 𝐓𝐨𝐦𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐈𝐦𝐚𝐠𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐂𝐨𝐫𝐨𝐧𝐚𝐫𝐲 𝐀𝐫𝐭𝐞𝐫𝐲 𝐍𝐞𝐨𝐢𝐧𝐭𝐢𝐦𝐚𝐥 𝐓𝐢𝐬𝐬𝐮𝐞
🔬 @www.helmholtz-munich.de I TUM Klinikum Deutsches Herzzentrum
🔎 Learn more:
www.ascenion.de/technologiea...
𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘀𝗲𝘁 𝗳𝗼𝗿 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗻𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗿𝗲𝗻𝗮𝗹 𝗰𝗲𝗹𝗹 𝗰𝗮𝗿𝗰𝗶𝗻𝗼𝗺𝗮𝘀
🔬 @imbavienna.bsky.social
🔎 www.biovaria.org/2025/biomark...
𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘀𝗲𝘁 𝗳𝗼𝗿 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗻𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗿𝗲𝗻𝗮𝗹 𝗰𝗲𝗹𝗹 𝗰𝗮𝗿𝗰𝗶𝗻𝗼𝗺𝗮𝘀
🔬 @imbavienna.bsky.social
🔎 www.biovaria.org/2025/biomark...
𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘀𝗲𝘁 𝗳𝗼𝗿 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗻𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗿𝗲𝗻𝗮𝗹 𝗰𝗲𝗹𝗹 𝗰𝗮𝗿𝗰𝗶𝗻𝗼𝗺𝗮𝘀
🔬@IMBA
🔎 Learn more: www.biovaria.org/2025/biomark...
𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿 𝘀𝗲𝘁 𝗳𝗼𝗿 𝗲𝗮𝗿𝗹𝘆 𝗮𝗻𝗱 𝗻𝗼𝗻-𝗶𝗻𝘃𝗮𝘀𝗶𝘃𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗿𝗲𝗻𝗮𝗹 𝗰𝗲𝗹𝗹 𝗰𝗮𝗿𝗰𝗶𝗻𝗼𝗺𝗮𝘀
🔬@IMBA
🔎 Learn more: www.biovaria.org/2025/biomark...
𝗡𝗼𝘃𝗲𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗳𝗼𝗿 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗹𝘂𝗻𝗴 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀
🔬 @Helmholtz Munich
🔎 Learn more: www.biovaria.org/2025/novel-t...
𝗡𝗼𝘃𝗲𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗳𝗼𝗿 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗹𝘂𝗻𝗴 𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀
🔬 @Helmholtz Munich
🔎 Learn more: www.biovaria.org/2025/novel-t...
𝗦𝗮𝗳𝗲𝗿 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗶𝘁𝗵 𝗜𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝗦𝗹𝗲𝗲𝗽𝗶𝗻𝗴 𝗕𝗲𝗮𝘂𝘁𝘆 (𝗦𝗕) 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝘀𝗮𝘀𝗲 𝗦𝘆𝘀𝘁𝗲𝗺 🧬
🔎 Learn more about this #technology on the #BioVaria website: www.biovaria.org/2025/safety-...
𝗦𝗮𝗳𝗲𝗿 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝘄𝗶𝘁𝗵 𝗜𝗺𝗽𝗿𝗼𝘃𝗲𝗱 𝗦𝗹𝗲𝗲𝗽𝗶𝗻𝗴 𝗕𝗲𝗮𝘂𝘁𝘆 (𝗦𝗕) 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝘀𝗮𝘀𝗲 𝗦𝘆𝘀𝘁𝗲𝗺 🧬
🔎 Learn more about this #technology on the #BioVaria website: www.biovaria.org/2025/safety-...
𝗠𝗔𝗟𝗩𝗔 – 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗦𝗽𝗮𝘁𝗶𝗮𝗹 (𝗧𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁)𝗼𝗺𝗶𝗰𝘀 𝗗𝗮𝘁𝗮 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀
🔬 @mdc-berlin.bsky.social - 𝗕𝗲𝗿𝗹𝗶𝗻 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗳𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗕𝗶𝗼𝗹𝗼𝗴𝘆
🔎 www.biovaria.org/2025/malva-371
𝗠𝗔𝗟𝗩𝗔 – 𝗥𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝗦𝗽𝗮𝘁𝗶𝗮𝗹 (𝗧𝗿𝗮𝗻𝘀𝗰𝗿𝗶𝗽𝘁)𝗼𝗺𝗶𝗰𝘀 𝗗𝗮𝘁𝗮 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀
🔬 @mdc-berlin.bsky.social - 𝗕𝗲𝗿𝗹𝗶𝗻 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗳𝗼𝗿 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗕𝗶𝗼𝗹𝗼𝗴𝘆
🔎 www.biovaria.org/2025/malva-371
Join us on April 7 and learn how to "Overcome CMC Challenges in the Development of Novel Biotherapeutics" from our expert Dr. Matthias Müllner, CEO & Co-Founder of bespark*bio.
📅 Date: April 7, 2025
🕒 Time: 11.30 am - 1.00 pm CET
👉 Register now: www.ascenion.de/service/go-b...
Join us on April 7 and learn how to "Overcome CMC Challenges in the Development of Novel Biotherapeutics" from our expert Dr. Matthias Müllner, CEO & Co-Founder of bespark*bio.
📅 Date: April 7, 2025
🕒 Time: 11.30 am - 1.00 pm CET
👉 Register now: www.ascenion.de/service/go-b...
𝗔𝗻 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗲𝗱 𝘀𝗲𝗿𝗶𝗻𝗲 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘀𝗲 𝗳𝗼𝗿 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗴𝗲𝗻𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗲𝗿 𝗶𝗻 𝗵𝘂𝗺𝗮𝗻 𝗰𝗲𝗹𝗹𝘀
🔬Charité
🔎 Learn more: www.biovaria.org/2025/an-engi...
𝗔𝗻 𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗲𝗱 𝘀𝗲𝗿𝗶𝗻𝗲 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘀𝗲 𝗳𝗼𝗿 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱 𝗴𝗲𝗻𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗲𝗿 𝗶𝗻 𝗵𝘂𝗺𝗮𝗻 𝗰𝗲𝗹𝗹𝘀
🔬Charité
🔎 Learn more: www.biovaria.org/2025/an-engi...